Skip to content
Beyond inspiring tomorrow’s farmers, FFA (formerly Future Farmers of America) also promotes careers in biotechnology. During FFA Week, the organization is making special efforts […]
FFA Week promotes careers in biotech for agriculture Read More »
With the new administration bringing new leadership to the Centers for Medicare & Medicaid Services (CMS), one of the most significant healthcare decisions facing
BIO’s message to incoming CMS leadership on improving Part D access for patients Read More »
Legislation introduced last year to ease widespread commercialization of sustainable aviation fuel (SAF) was reintroduced Jan. 16 as one of the early measures proposed
Farm to Fly Act reintroduced in Senate would give SAF wings Read More »
The world needs regulatory reform and greater R&D investment to enable “moonshot” biotech innovations in food production that can meet our growing food needs,
Nobel and World Food Prize holders: Enable biotech innovation for food Read More »
Pharmacy benefit managers (PBMs) make billions in profit while driving up the price of prescription drugs with markups that can exceed 1,000%, according to
FTC’s second report on PBMs blasts drug price markups of 1,000% Read More »
As science progresses, we need parallel progress in making breakthrough treatments widely available, BIO President & CEO John F. Crowley said at a Jan.
BIO CEO urges innovation in access at White House CGT forum Read More »
The Centers for Medicare & Medicaid Services (CMS) issued a directive telling private insurers providing Medicare Advantage (MA) plans to cover Biogen’s amyotrophic lateral sclerosis
CMS directs insurers to cover ALS drug Qalsody Read More »
The U.S. bioscience industry generated $3.2 trillion in overall output in 2023, according to the latest report from the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience
U.S. biotech generates $3.2 trillion in a year, report shows Read More »
Pictured above, Rep. Deborah Ross (D-NC) addresses the opening session of BIO’s Intellectual Property Counsels Committee Conference in Washington, D.C., on Nov. 18. The
BIO IP conference promotes protection of innovation Read More »
The U.S. Department of Agriculture (USDA) on Nov. 12 announced that biotech plants made through modifications that could have been achieved by conventional breeding can be
APHIS exempts more types of biotech plants from regulation Read More »
